Antioxidant supplementation and cancer patients receiving curative-intent chemotherapy

Peter J Smith and Kathryn J Steadman
Med J Aust 2016; 204 (5): . || doi: 10.5694/mja15.01196
Published online: 21 March 2016

Much of the advice in the lay press regarding the benefits of antioxidants for people undergoing cancer treatment does not qualify or differentiate between curative and palliative cancer treatment or the type of cancer treatment involved.

  • 1 Sunshine Coast Cancer Care Services, Nambour General Hospital, Nambour, QLD
  • 2 University of Queensland, Brisbane, QLD

Competing interests:

No relevant disclosures.

  • 1. Gianni AM, Piccart MJ. Optimising chemotherapy dose density and dose intensity. Eur J Cancer 2000; 36 Suppl 1: S1-3.
  • 2. Hudis C, Dang C. The development of dose-dense adjuvant chemotherapy. Breast J 2015; 21: 42-51.
  • 3. Lawenda BD, Kelly KM, Ladas EJ, et al. Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy? J Natl Cancer Inst 2008; 100: 773-783.
  • 4. D’Andrea GM. Use of antioxidants during chemotherapy and radiotherapy should be avoided. CA Cancer J Clin 2005; 55: 319-321.
  • 5. Block KI, Koch AC, Mead MN, et al. Impact of antioxidant supplementation on chemotherapeutic efficacy: a systematic review of the evidence from randomized controlled trials. Cancer Treat Rev 2007; 33: 407-418.
  • 6. Yasueda A, Urushima H, Ito T. Efficacy and interaction of antioxidant supplements as adjuvant therapy in cancer treatment: a systematic review. Integr Cancer Ther 2016; 15: 17-39.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.